AUTH/2816/12/15: Anonymous v Allergan — allegation of large payments to doctors to endorse Botox (No breach)

📅 2015 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2816/12/15
PartiesAnonymous v Allergan
AllegationLarge payments to doctors to endorse Botox and other products
Complaint received16 December 2015
Case completed21 January 2016
Applicable Code year2015
Clauses considered2, 9.1 and 18.1
Panel decisionNo breach
AppealNo appeal
SanctionsNone
Notable case pointsComplainant non-contactable and provided no detail; Panel found no evidence to support allegation; company referenced policies/procedures and transfer-of-value disclosure

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous complainant alleged “large payments made by Allergan to top doctors to endorse Botox and other products”.
  • The complainant was initially contactable but later became non-contactable and provided no specifics (no dates, recipients, or examples).
  • The PMCPA asked Allergan to respond in relation to Clauses 2, 9.1 and 18.1 of the Code.
  • Allergan denied the allegation and described its policies and procedures governing HCP engagements, anti-bribery/anti-corruption controls, consultancy contracting, fair market value (FMV) rates, and internal approval processes.
  • Allergan stated it disclosed transfers of value as required by the Code and provided aggregate consultant payment figures for 2012–2014.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel found no evidence to support the allegation, noting the lack of detail and inability to obtain further information from the complainant.
  • No breach of Clauses 2, 9.1 and 18.1 was ruled.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training